Stem Cell Therapy Market Report Scope & Overview
The Stem Cell Therapy Market size was valued at USD 336.07 million in 2024 and expected to reach USD 1,113.12 million by 2032, growing at a CAGR of 17.10% over the forecast period 2025-2032.
The lifted burden of chronic diseases has resulted in the advancement of regenerative stem cell therapy which is being investigated as a good therapeutic agent for these fatal disorders. As an illustration, in December 2023 Mayo Clinic researchers and international collaborators showed that the propagation of stem cell-based regenerative therapy was effective for advanced heart failure.
-
In the January 2023 postponement period, UC Davis Health researchers showed that a stem cell therapy for treating Crohn's disease in preclinical trials fared well. Therefore, the augmented research undertaking in stem cell therapy is expected to drive industry expansion during the forecast years.
Additionally, burgeoning funding/grants to design prospective stem cell-based therapeutics are further anticipated to uphold the market growth. To strengthen its work towards the creation of cutting-edge stem cell treatments to treat several deadly illnesses, CellVoyant supported GBP 7.6 million (USD9.49 million) from Octopus Ventures in January 2024 as an illustration Likewise, in February 2023 the National Institutes of Health awarded USD 2.5 million to a group at Purdue University for stem cell research on which they are working with allogeneic ISCTCs into phase III testing. Therefore, such cash flow activities are expected to fuel the growth of the industry.
To Get More Information On Stem Cell Therapy Market - Request Free Sample Report
Stem Cell Therapy Market Report Highlights
Stem Cell Therapy Market Drivers
-
Increasing Prevalence of Chronic Disorders is responsible for the Increasing Demand for Stem Cell Therapy Solutions.
The increasing prevalence of chronic disorders worldwide is a primary driver for the growing demand for stem cell therapy solutions. Chronic diseases such as cancer, cardiovascular disorders, diabetes, and autoimmune conditions are on the rise due to aging populations, sedentary lifestyles, and environmental factors. According to the World Health Organization (WHO), chronic diseases account for approximately 71% of all global deaths, with cancer alone responsible for nearly 10 million deaths annually. The United States Centers for Disease Control and Prevention (CDC) reports that around 60% of adults in the U.S. live with at least one chronic condition, and nearly 40% manage two or more. These alarming statistics underscore the need for advanced therapeutic approaches beyond conventional treatments. Stem cell therapies offer regenerative potential, enabling repair or replacement of damaged tissues and improved treatment outcomes. For instance, hematopoietic stem cell transplants are widely used in treating blood-related cancers, while mesenchymal stem cells are being explored for cardiovascular repair and autoimmune disorders. The growing acceptance of stem cell banking and personalized medicine further supports market expansion, as patients seek long-term therapeutic solutions. Consequently, the increasing global burden of chronic disorders is expected to sustain the adoption of stem cell therapy, making it a critical segment in regenerative medicine over the coming decade.
-
The Growing Demand for Stem Cell Banking is Boosting the Market Growth.
Restraints:
-
Stringent Regulatory Scenario is Hindering Stem Cell Therapy Market Growth.
The stringent regulatory environment is a significant restraint on the growth of the stem cell therapy market. Regulatory agencies across the globe, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other regional authorities, impose rigorous requirements for clinical trials, safety assessments, and approval processes for stem cell-based products. These regulations are intended to ensure patient safety and efficacy but often result in lengthy approval timelines and high compliance costs. For example, the FDA mandates extensive preclinical and clinical studies before granting approval for stem cell therapies, which can delay market entry by several years. Additionally, variations in regulatory frameworks between countries create challenges for companies aiming to commercialize therapies internationally. Complex guidelines related to ethical sourcing, manipulation of stem cells, and quality control add further hurdles. High costs associated with regulatory compliance can be prohibitive for smaller companies or startups, limiting innovation and slowing market expansion. As a result, despite the growing demand for stem cell therapies, strict regulatory oversight continues to impede rapid commercialization and adoption of these advanced treatments globally.
-
The Higher Costs of Stem Cell Therapy Procedures Can Limit the Adoption of Stem Cell Therapy.
Stem Cell Therapy Market Opportunities:
-
Technological Advancements are Offering a Lucrative Growth Opportunity for Stem Cell Therapy Procedures.
-
Hefty R&D Investments are Responsible for the Market Growth During Upcoming Years.
Stem Cell Therapy Market Sgmentation Analysis
By Therapy
In terms of revenue generation, the Allogenic therapy segment held for 60% share of this market in 2023. The growth in this segment can be attributed to factors such as the high cost of treatment and increasing stem cell banking. In addition, a lot of cell therapy companies are waiving their business from autologous and moving on to allogenic. As a consequence, this segment is anticipated to push up the growth of the equivalent market.
Further, the competitive moves by major market players to enhance their product offerings will also provide significant prospects over the forecast period. For example, Acepodia raised USD 47M in Series B financing for its allogenic cell therapy candidates’ pipeline just this March of 2021. Later, in June 2022, Immatics had done partnership for developing gamma delta allogeneic cell therapy programs while extending its collaboration with the pharmaceutical firm Bristol Myers Squibb.
By Product
Adult Stem Cells held a market share of 76.36% by the year 202 as this is done without destruction while Embryonic stem cells are destroyed adult stem cells do not carry the threat of graft rejection. Increasing cell banking services along with the development in biopreservation and cryopreservation are expected to drive adult stem cell demand. Adult cells suffer from fewer ethical concerns, further driving the market for this segment. Autologous transformation, low risk of tumor formation, and established treatment options are the several benefits in the US that can be achieved through the adult stem cell banking segment in next forthcoming years.
By Application
An increase in the incidence of cancer and malignancies is expected to drive segmental growth; responsible for 32% market share by 2023. Cancer Australia, for example, states up to 4,600 people will be diagnosed with kidney cancer this year compared to 4,552 in the last calendar period. Kidney cancer is ranked the seventh most common cause of diagnosis in Australia with around 1 in every 65 Australians being afflicted. The increasing prevalence of cancer is expected to further boost the demand for cell therapies such as stem cell therapy to treat it efficiently.
Moreover, in the past few years stem cells have been useful for the repopulation of blood and also immuno-reconstitution following cancer treatment. Moreover, these cells have gained immense popularity among the scientific fraternity as a modality for anti-tumor agent delivery and their utility in tissue regeneration. Quite a few bodies have after implementation also praised this tumor-treating mode. As of data from the Da Vinci Wellness Center (DVC Stem) in October 2023, stem cells have a notable success rate for cancer where around 87.5% experienced improvements.
Stem Cell Therapy Market Regional Insights
North America Stem Cell Therapy Market Growth
In North America, the market accounted for 44% of the market share owing to the higher incidence rates combined with rising research in stem cell therapies, increased adoption of regenerative medicine within the region, and supportive regulatory framework.
The rise in the incidence of cancer cases in the US will drive market growth. In the same way, based on this data more people will have mouth cancer in 2024 as per the American Cancer Society which was around to report about 15,490 such cases compared with that of the previous year when it reported only --14,820. This is anticipated to propel the demand for stem cell therapies globally as a portion of these therapies are used in advanced cancer treatments, thus subsequently driving the growth of the stem cell therapy market during the projected timeframe.
An increasing focus on the potential of stem cells in cancer management has spurred researchers to explore cell-mediated therapies for various types of cancers. Stem cell therapies in cancer were highlighted by Cedars-Sinai scientists earlier this year, showing how they increase the effectiveness of standard treatments (January 2022).
Likewise, in December 2022 City of Hope and its Alpha Stem Cell Clinic received an $8 million grant from the California Institute of Regenerative Medicine for its work with regenerative medicine and cancer. Therefore, any increase in these research efforts is likely to support the growth of regional stem cell therapy markets.
Get Customized Report as Per Your Business Requirement - Enquiry Now
Stem Cell Therapy Market Key Players
-
Thermo Fisher Scientific, Inc.
-
Merck KGaA
-
CellGenix GmbH
-
Takara Bio
-
Cellartis AB
-
AcceGen
-
Cell Applications, Inc.
-
ATCC
-
Bio-Techne
-
STEMCELL Technologies Inc. & other players.
Stem Cell Therapy Market Competitive Landscape
-
In December 2023, The University of Texas at San Antonio (UTSA) and BioBridge Global subsidiary GenCure signed a master services agreement that formalized their partnership. The agreement details their collaborations to drive the cell therapy product and service development process.
-
In September 2023, The SKAN Research Trust shared its operations with Wellcome-MRC Cambridge Stem Cell Institute hosted in September. They saw a joint research program into the genomic architecture of age-related neurodegeneration diseases in an Indian population.
Stem Cell Therapy Market Report Scope:
| Report Attributes | Details |
| Market Size in 2024 | US$ 336.07 Million |
| Market Size by 2032 | US$ 1,113.12 Million |
| CAGR | CAGR of 17.10% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Product (Adult Stem Cells (ASCs), Human Embryonic Stem Cells (HESCs), Induced Pluripotent Stem Cells (iPSCs) & Very Small Embryonic Like Stem Cells) •By Application (Neurological Disorders, Orthopaedic Treatments, Oncology Disorders, Injuries and Wounds, Cardiovascular Disorders & Others) •By Therapy (Allogeneic, Autologic & Syngeneic) •By End-Use (Pharmaceutical & Biotechnology Companies, Hospitals & Cell Banks & Academic & Research Institutes) •By Technology (Cell Acquisition, Cell Production, Cryopreservation & Expansion and Sub-Culture) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Thermo Fisher Scientific, Inc., Lonza, Merck KGaA, CellGenix GmbH, Takara Bio, Cellartis AB, AcceGen, Cell Applications, Inc., ATCC, PromoCell GmbH, Bio-Techne, STEMCELL Technologies Inc. & other players |
Table Of Contents
1. Introduction
1.1 Market Definition & Scope
1.2 Research Assumptions & Abbreviations
1.3 Research Methodology
2. Executive Summary
2.1 Market Snapshot
2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2021–2032
2.3 Market Size & Forecast, By Segmentation, 2021–2032
2.3.1 Market Size By Product
2.3.2 Market Size By Application
2.3.2 Market Size By Therapy
2.3.2 Market Size By End-User
2.3.2 Market Size By Technology
2.4 Market Share & BPS Analysis By Region, 2024
2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic
2.6 Industry CxO’s Perspective
3. Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Key Market Trends
3.2 Industry PESTLE Analysis
3.3 Key Industry Forces (Porter’s) Impacting Market Growth
3.4 Industry Supply Chain Analysis
3.4.1 Raw Material Suppliers
3.4.2 Manufacturers
3.4.3 Distributors/Suppliers
3.4.4 Customers/End-Users
3.5 Industry Life Cycle Assessment
3.6 Parent Market Overview
3.7 Market Risk Assessment
4. Statistical Insights & Trends Reporting
4.1 Clinical Trials & Research Metrics
4.1.1 Number of ongoing stem cell therapy clinical trials by type (autologous vs. allogeneic)
4.1.2 Average patient enrollment per trial phase (I, II, III)
4.1.3 Success rate (%) of clinical trials leading to regulatory approval
4.2 Application & Treatment Trends
4.2.1 Share of stem cell therapies by therapeutic area (orthopedic, hematology, neurology, cardiovascular)
4.2.2 Average number of stem cell doses administered per patient per treatment cycle
4.2.3 Adoption rate (%) of stem cell therapy in hospitals vs. specialized clinics
4.3 Regulatory & Approval Insights
4.3.1 Number of stem cell therapies approved by region/country annually
4.3.2 Average time-to-approval (months/years) by regulatory authority
4.3.3 Share (%) of therapies complying with GMP (Good Manufacturing Practices) standards
4.4 Manufacturing & Supply Chain Metrics
4.4.1 Average production yield of stem cells per batch by cell type
4.4.2 Cost breakdown: harvesting vs. processing vs. storage
4.4.3 Distribution of stem cell manufacturing facilities by continent
5. Stem Cell Therapy Market Segmental Analysis & Forecast, By Product, 2021 – 2032, Value (USD Million)
5.1 Introduction
5.2 Adult Stem Cells (ASCs)
5.2.1 Key Trends
5.2.2 Market Size & Forecast, 2021 – 2032
5.3 Human Embryonic Stem Cells (HESCs)
5.3.1 Key Trends
5.3.2 Market Size & Forecast, 2021 – 2032
5.4 Induced Pluripotent Stem Cells (iPSCs)
5.4.1 Key Trends
5.4.2 Market Size & Forecast, 2021 – 2032
5.5 Very Small Embryonic Like Stem Cells
5.5.1 Key Trends
5.5.2 Market Size & Forecast, 2021 – 2032
6. Stem Cell Therapy Market Segmental Analysis & Forecast, By Application, 2021 – 2032, Value (USD Million)
6.1 Introduction
6.2 Neurological Disorders
6.2.1 Key Trends
6.2.2 Market Size & Forecast, 2021 – 2032
6.3 Orthopaedic Treatments
6.3.1 Key Trends
6.3.2 Market Size & Forecast, 2021 – 2032
6.4 Oncology Disorders
6.4.1 Key Trends
6.4.2 Market Size & Forecast, 2021 – 2032
6.5 Injuries and Wounds
6.5.1 Key Trends
6.5.2 Market Size & Forecast, 2021 – 2032
6.6 Cardiovascular Disorders
6.6.1 Key Trends
6.6.2 Market Size & Forecast, 2021 – 2032
6.7 Others
6.7.1 Key Trends
6.7.2 Market Size & Forecast, 2021 – 2032
7. Stem Cell Therapy Market Segmental Analysis & Forecast, By Therapy, 2021 – 2032, Value (USD Million)
7.1 Introduction
7.2 Allogeneic
7.2.1 Key Trends
7.2.2 Market Size & Forecast, 2021 – 2032
7.3 Autologic
7.3.1 Key Trends
7.3.2 Market Size & Forecast, 2021 – 2032
7.4 Syngeneic
7.4.1 Key Trends
7.4.2 Market Size & Forecast, 2021 – 2032
8. Stem Cell Therapy Market Segmental Analysis & Forecast, By End-User, 2021 – 2032, Value (USD Million)
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Key Trends
8.2.2 Market Size & Forecast, 2021 – 2032
8.3 Hospitals & Cell Banks
8.3.1 Key Trends
8.3.2 Market Size & Forecast, 2021 – 2032
8.4 Academic & Research Institutes
8.4.1 Key Trends
8.4.2 Market Size & Forecast, 2021 – 2032
9. Stem Cell Therapy Market Segmental Analysis & Forecast, By Technology, 2021 – 2032, Value (USD Million)
9.1 Introduction
9.2 Cell Acquisition
9.2.1 Key Trends
9.2.2 Market Size & Forecast, 2021 – 2032
9.3 Cell Production
9.3.1 Key Trends
9.3.2 Market Size & Forecast, 2021 – 2032
9.4 Cryopreservation
9.4.1 Key Trends
9.4.2 Market Size & Forecast, 2021 – 2032
9.5 Expansion and Sub-Culture
9.5.1 Key Trends
9.5.2 Market Size & Forecast, 2021 – 2032
10. Stem Cell Therapy Market Segmental Analysis & Forecast By Region, 2021 – 2032, Value (USD Million)
10.1 Introduction
10.2 North America
10.2.1 Key Trends
10.2.2 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.2.3 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.2.4 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.2.5 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.2.6 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.2.7 Stem Cell Therapy Market Size & Forecast, By Country, 2021 – 2032
10.2.7.1 USA
10.2.7.1.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.2.7.1.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.2.7.1.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.2.7.1.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.2.7.1.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.2.7.2 Canada
10.2.7.2.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.2.7.2.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.2.7.2.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.2.7.2.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.2.7.2.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.3 Europe
10.3.1 Key Trends
10.3.2 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.3.3 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.3.4 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.3.5 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.3.6 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.3.7 Stem Cell Therapy Market Size & Forecast, By Country, 2021 – 2032
10.3.7.1 Germany
10.3.7.1.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.3.7.1.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.3.7.1.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.3.7.1.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.3.7.1.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.2 UK
10.3.7.2.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.3.7.2.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.3.7.2.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.3.7.2.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.3.7.2.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.3 France
10.3.7.3.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.3.7.3.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.3.7.3.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.3.7.3.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.3.7.3.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.4 Italy
10.3.7.4.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.3.7.4.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.3.7.4.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.3.7.4.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.3.7.4.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.5 Spain
10.3.7.5.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.3.7.5.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.3.7.5.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.3.7.5.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.3.7.5.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.6 Russia
10.3.7.6.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.3.7.6.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.3.7.6.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.3.7.6.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.3.7.6.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.7 Poland
10.3.7.7.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.3.7.7.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.3.7.7.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.3.7.7.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.3.7.7.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.3.7.8 Rest of Europe
10.3.7.8.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.3.7.8.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.3.7.8.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.3.7.8.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.3.7.8.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.4 Asia-Pacific
10.4.1 Key Trends
10.4.2 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.4.3 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.4.4 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.4.5 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.4.6 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.4.7 Stem Cell Therapy Market Size & Forecast, By Country, 2021 – 2032
10.4.7.1 China
10.4.7.1.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.4.7.1.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.4.7.1.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.4.7.1.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.4.7.1.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.2 India
10.4.7.2.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.4.7.2.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.4.7.2.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.4.7.2.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.4.7.2.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.3 Japan
10.4.7.3.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.4.7.3.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.4.7.3.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.4.7.3.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.4.7.3.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.4 South Korea
10.4.7.4.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.4.7.4.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.4.7.4.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.4.7.4.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.4.7.4.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.5 Australia
10.4.7.5.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.4.7.5.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.4.7.5.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.4.7.5.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.4.7.5.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.6 ASEAN Countries
10.4.7.6.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.4.7.6.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.4.7.6.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.4.7.6.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.4.7.6.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.4.7.7 Rest of Asia-Pacific
10.4.7.7.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.4.7.7.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.4.7.7.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.4.7.7.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.4.7.7.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.5 Latin America
10.5.1 Key Trends
10.5.2 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.5.3 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.5.4 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.5.5 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.5.6 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.5.7 Stem Cell Therapy Market Size & Forecast, By Country, 2021 – 2032
10.5.7.1 Brazil
10.5.7.1.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.5.7.1.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.5.7.1.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.5.7.1.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.5.7.1.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.5.7.2 Argentina
10.5.7.2.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.5.7.2.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.5.7.2.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.5.7.2.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.5.7.2.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.5.7.3 Mexico
10.5.7.3.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.5.7.3.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.5.7.3.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.5.7.3.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.5.7.3.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.5.7.4 Colombia
10.5.7.4.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.5.7.4.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.5.7.4.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.5.7.4.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.5.7.4.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.5.7.5 Rest of Latin America
10.5.7.5.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.5.7.5.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.5.7.5.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.5.7.5.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.5.7.5.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.6 Middle East & Africa
10.6.1 Key Trends
10.6.2 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.6.3 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.6.4 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.6.5 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.6.6 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.6.7 Stem Cell Therapy Market Size & Forecast, By Country, 2021 – 2032
10.6.7.1 UAE
10.6.7.1.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.6.7.1.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.6.7.1.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.6.7.1.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.6.7.1.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.6.7.2 Saudi Arabia
10.6.7.2.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.6.7.2.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.6.7.2.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.6.7.2.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.6.7.2.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.6.7.3 Qatar
10.6.7.3.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.6.7.3.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.6.7.3.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.6.7.3.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.6.7.3.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.6.7.4 Egypt
10.6.7.4.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.6.7.4.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.6.7.4.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.6.7.4.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.6.7.4.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.6.7.5 South Africa
10.6.7.5.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.6.7.5.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.6.7.5.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.6.7.5.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.6.7.5.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
10.6.7.6 Rest of Middle East & Africa
10.6.7.6.1 Stem Cell Therapy Market Size & Forecast, By Product, 2021 – 2032
10.6.7.6.2 Stem Cell Therapy Market Size & Forecast, By Application, 2021 – 2032
10.6.7.6.3 Stem Cell Therapy Market Size & Forecast, By Therapy, 2021 – 2032
10.6.7.6.4 Stem Cell Therapy Market Size & Forecast, By End-User, 2021 – 2032
10.6.7.6.5 Stem Cell Therapy Market Size & Forecast, By Technology, 2021 – 2032
11. Competitive Landscape
11.1 Key Players' Positioning
11.2 Competitive Developments
11.2.1 Key Strategies Adopted (%), By Key Players, 2024
11.2.2 Year-Wise Strategies & Development, 2021 – 2025
11.2.3 Number Of Strategies Adopted By Key Players, 2024
11.3 Market Share Analysis, 2024
11.4 Product/Service & Application Benchmarking
11.4.1 Product/Service Specifications & Features By Key Players
11.4.2 Product/Service Heatmap By Key Players
11.4.3 Application Heatmap By Key Players
11.5 Industry Start-Up & Innovation Landscape
11.6 Key Company Profiles
11.6 Key Company Profiles
11.6.1 Novartis AG
11.6.1.1 Company Overview & Snapshot
11.6.1.2 Product/Service Portfolio
11.6.1.3 Key Company Financials
11.6.1.4 SWOT Analysis
11.6.2 Mesoblast Ltd.
11.6.2.1 Company Overview & Snapshot
11.6.2.2 Product/Service Portfolio
11.6.2.3 Key Company Financials
11.6.2.4 SWOT Analysis
11.6.3 TiGenix
11.6.3.1 Company Overview & Snapshot
11.6.3.2 Product/Service Portfolio
11.6.3.3 Key Company Financials
11.6.3.4 SWOT Analysis
11.6.4 Vertex Pharmaceuticals
11.6.4.1 Company Overview & Snapshot
11.6.4.2 Product/Service Portfolio
11.6.4.3 Key Company Financials
11.6.4.4 SWOT Analysis
11.6.5 Gamida Cell
11.6.5.1 Company Overview & Snapshot
11.6.5.2 Product/Service Portfolio
11.6.5.3 Key Company Financials
11.6.5.4 SWOT Analysis
11.6.6 BlueRock Therapeutics
11.6.6.1 Company Overview & Snapshot
11.6.6.2 Product/Service Portfolio
11.6.6.3 Key Company Financials
11.6.6.4 SWOT Analysis
11.6.7 Cellino Biotech
11.6.7.1 Company Overview & Snapshot
11.6.7.2 Product/Service Portfolio
11.6.7.3 Key Company Financials
11.6.7.4 SWOT Analysis
11.6.8 Fate Therapeutics
11.6.8.1 Company Overview & Snapshot
11.6.8.2 Product/Service Portfolio
11.6.8.3 Key Company Financials
11.6.8.4 SWOT Analysis
11.6.9 Garuda Therapeutics
11.6.9.1 Company Overview & Snapshot
11.6.9.2 Product/Service Portfolio
11.6.9.3 Key Company Financials
11.6.9.4 SWOT Analysis
11.6.10 Sana Biotechnology
11.6.10.1 Company Overview & Snapshot
11.6.10.2 Product/Service Portfolio
11.6.10.3 Key Company Financials
11.6.10.4 SWOT Analysis
11.6.11 Aspen Neuroscience
11.6.11.1 Company Overview & Snapshot
11.6.11.2 Product/Service Portfolio
11.6.11.3 Key Company Financials
11.6.11.4 SWOT Analysis
11.6.12 Orca Bio
11.6.12.1 Company Overview & Snapshot
11.6.12.2 Product/Service Portfolio
11.6.12.3 Key Company Financials
11.6.12.4 SWOT Analysis
11.6.13 CellProthera
11.6.13.1 Company Overview & Snapshot
11.6.13.2 Product/Service Portfolio
11.6.13.3 Key Company Financials
11.6.13.4 SWOT Analysis
11.6.14 Century Therapeutics
11.6.14.1 Company Overview & Snapshot
11.6.14.2 Product/Service Portfolio
11.6.14.3 Key Company Financials
11.6.14.4 SWOT Analysis
11.6.15 Cytovia Therapeutics
11.6.15.1 Company Overview & Snapshot
11.6.15.2 Product/Service Portfolio
11.6.15.3 Key Company Financials
11.6.15.4 SWOT Analysis
11.6.16 Cynata Therapeutics
11.6.16.1 Company Overview & Snapshot
11.6.16.2 Product/Service Portfolio
11.6.16.3 Key Company Financials
11.6.16.4 SWOT Analysis
11.6.17 JCR Pharmaceuticals Co., Ltd.
11.6.17.1 Company Overview & Snapshot
11.6.17.2 Product/Service Portfolio
11.6.17.3 Key Company Financials
11.6.17.4 SWOT Analysis
11.6.18 Takeda Pharmaceutical Company Limited
11.6.18.1 Company Overview & Snapshot
11.6.18.2 Product/Service Portfolio
11.6.18.3 Key Company Financials
11.6.18.4 SWOT Analysis
11.6.19 Bristol-Myers Squibb Company
11.6.19.1 Company Overview & Snapshot
11.6.19.2 Product/Service Portfolio
11.6.19.3 Key Company Financials
11.6.19.4 SWOT Analysis
11.6.20 Gilead Sciences, Inc.
11.6.20.1 Company Overview & Snapshot
11.6.20.2 Product/Service Portfolio
11.6.20.3 Key Company Financials
11.6.20.4 SWOT Analysis
12. Analyst Recommendations
12.1 SNS Insider Opportunity Map
12.2 Industry Low-Hanging Fruit Assessment
12.3 Market Entry & Growth Strategy
12.4 Analyst Viewpoint & Suggestions On Market Growth
13. Assumptions
14. Disclaimer
15. Appendix
15.1 List Of Tables
15.2 List Of Figures
Key Market Segments:
By Product
-
Adult Stem Cells (ASCs)
-
Human Embryonic Stem Cells (HESCs)
-
Induced Pluripotent Stem Cells (iPSCs)
-
Very Small Embryonic Like Stem Cells
By Application
-
Neurological Disorders
-
Orthopaedic Treatments
-
Oncology Disorders
-
Injuries and Wounds
-
Cardiovascular Disorders
-
Others
By Therapy
-
Allogeneic
-
Autologic
-
Syngeneic
By End-Use
-
Pharmaceutical & Biotechnology Companies
-
Hospitals & Cell Banks
-
Academic & Research Institutes
By Technology
-
Cell Acquisition
-
Cell Production
-
Cryopreservation
-
Expansion and Sub-Culture
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
-
Europe
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
-
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of Middle East
-
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
-
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
